News Our latest news and announcements.


How Hard Is It To Use MarginProbe®?

Dr. Beth-Ann Lesnikoski, MD, explains the ease in using MarginProbe.

Video: Whole Cavity Shaving Animation

Watch a video with an animation explaining whole cavity shave.

The American Society of Breast Surgeons Annual Meeting 2017

[vc_row][vc_column][vc_column_text] Collectively improving the standard of breast cancer treatment at ASBrS 2017 About the American Society of…

MarginProbe® Reduces Positive Margin Rate by Half for Nevada Surgeon

Dr. Joseph Contino worked with MountainView Hospital in Las Vegas, Nevada for more than a year evaluating MarginProbe, a new piece of technology being used in the fight against breast cancer.

Connect with the Dilon Team at Miami Breast 2017

[vc_row][vc_column][vc_column_text]For more than three decades, the annual Miami Breast Cancer Conference (MBCC) has brought together surgical, medical…

MarginProbe® Assists Breast Surgeons when Performing Oncoplastic Surgery

Dr. Barber discusses the benefits of using MarginProbe in the operating room.

Physician Insight for Patients: Dr. Vincent Reid – MarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers

MarginProbe®  Gives Patients the Best Chance for Only One Lumpectomy Procedure for Both Invasive and DCIS Breast Cancers

Physician Insight for Patients: Dr. Jeffrey Falk – Early Study Data Supports the Value of MarginProbe® in Getting all the Cancer in the First Lumpectomy Surgery

Dr. Falk and his partner recently completed an evaluation comparing 120 cases using MarginProbe to 120 cases prior to that using the new technology.

Physician Insight for Patients: Dr. Melanie Friedlander – MarginProbe® Greatly Enhances Outcomes with DCIS Breast Cancer Surgery

Dr. Melanie Friedlander, South Bay Surgeons: Specializes in General Surgery, Breast Surgery, Advanced Laparoscopic Surgery, Thyroid and Parathyroid surgery.

MarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers

Dr. Reid is a firm believer in the success of MarginProbe in improving the results of breast cancer surgery.

Surgeon Spotlight: Dr. Jeffrey Falk – Early Study Data Supports the Value of MarginProbe® in Getting All the Cancer in the First Lumpectomy Surgery

Dr. Jeffrey Falk is a surgical oncologist focusing primarily on breast cancer since starting his practice in 2001. He performs 200-350 breast cancer surgeries annually and has a special interest in research and clinical trials for breast cancer treatments.

Mapping Breast Tissue Types by Miniature Radio-Frequency Near-Field Spectroscopy Sensor in Ex-Vivo Freshly Excised Specimens

[vc_row][vc_column][vc_column_text]Zvi Kaufman,1,7 Haim Paran,1 Ilana Haas,1 Patricia Malinger,1 Tania Zehavi,2 Tamar Karni,3 Izhak Pappo,3 Judith Sandbank,4 Judith…

How can we help?

Before you commit to a particular
course of treatment, talk to us.